UnitedHealth Group (NYSE:UNH) Announces Earnings Results

Key Points

• Q4 beat: UnitedHealth reported $2.11 EPS versus $2.09 expected and revenue rose 12.3% year‑over‑year, and it updated its FY2026 adjusted EPS guidance to about $17.75.
• $1.6 billion restructuring charge cut Q4 profit to roughly $10 million and the company issued a weaker 2026 revenue outlook (around $439B vs. the street ~ $456.6B), which spurred negative market reaction.
• The company paid a quarterly dividend of $2.21 (annualized $8.84) for a yield of ~2.5% and a dividend payout ratio near 46%, while institutional investors hold about 87.9% of the stock.

UnitedHealth Group (NYSE:UNH - Get Free Report) released its quarterly earnings data on Tuesday. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02, Zacks reports. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group's revenue was up 12.3% compared to the same quarter last year. During the same period in the prior year, the company posted $6.81 EPS. UnitedHealth Group updated its FY 2026 guidance to 17.750- EPS.

UnitedHealth Group Trading Down 1.1%

UNH stock opened at $352.32 on Tuesday. The business's 50-day moving average is $332.71 and its 200 day moving average is $323.96. UnitedHealth Group has a 12-month low of $234.60 and a 12-month high of $606.36. The stock has a market cap of $319.15 billion, a price-to-earnings ratio of 18.39, a PEG ratio of 2.15 and a beta of 0.42. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is currently 46.14%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Riggs Asset Managment Co. Inc. grew its holdings in shares of UnitedHealth Group by 69.4% during the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate's stock worth $33,000 after buying an additional 43 shares in the last quarter. Sittner & Nelson LLC grew its stake in UnitedHealth Group by 7.2% during the 3rd quarter. Sittner & Nelson LLC now owns 682 shares of the healthcare conglomerate's stock valued at $236,000 after acquiring an additional 46 shares in the last quarter. Keystone Financial Group lifted its stake in UnitedHealth Group by 3.1% in the 3rd quarter. Keystone Financial Group now owns 1,708 shares of the healthcare conglomerate's stock worth $588,000 after purchasing an additional 51 shares in the last quarter. Imprint Wealth LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $33,000. Finally, Voya Financial Advisors Inc. boosted its stake in UnitedHealth Group by 2.6% during the second quarter. Voya Financial Advisors Inc. now owns 4,334 shares of the healthcare conglomerate's stock worth $1,340,000 after buying an additional 109 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on UNH shares. TD Cowen increased their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a "hold" rating in a research report on Thursday, October 30th. Wells Fargo & Company lifted their price target on UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a research report on Tuesday, October 7th. KeyCorp upped their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 8th. Jefferies Financial Group boosted their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a "buy" rating in a research note on Friday, October 17th. Finally, Barclays lifted their price objective on shares of UnitedHealth Group from $386.00 to $391.00 and gave the company an "overweight" rating in a report on Monday, January 5th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $386.33.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth forecast 2026 adjusted profit slightly above analysts' estimates, signaling that initial cost-control measures may be working. Read More.
• Positive Sentiment: Analysts note UnitedHealth's decision to rebate ACA profits and other moves as strategically positive for reputation and competitive positioning. Read More.
• Neutral Sentiment: UnitedHealth posted a modest Q4 earnings beat and 12% consolidated revenue growth for 2025, showing operational resilience even as margins are pressured. Read More.
• Neutral Sentiment: The company reiterated its turnaround progress in its press release while providing updated full-year outlook metrics. Read More.
• Negative Sentiment: UnitedHealth took a $1.6 billion restructuring charge that pushed Q4 profit down to about $10 million — a large one-time hit that clouds near-term earnings. Read More.
• Negative Sentiment: The company issued weaker 2026 revenue guidance (around $439B vs. street ~$456.6B), signaling expected revenue decline and slower top-line growth next year — the main driver of today's negative reaction. Read More.
• Negative Sentiment: Regulatory/policy headwinds: the Trump administration proposed nearly flat Medicare Advantage rates for 2026, removing a key tailwind for UnitedHealthcare and prompting sector-wide selling. Read More.
• Negative Sentiment: Market reaction and trading scrutiny: shares plunged on the news and a recent trade filing by a congressman has drawn attention, adding short-term negative sentiment and volatility risk. Read More.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.